Post-Covid-19 Epidemic Era, Opioid Withdrawal Syndrome Industry Development Trend Analysis Report 2023
MARKET COMPETITIVE LANDSCAPE:
Major players in this market include Indivior, Alkermes, Mallinckrodt Pharmaceuticals, Camurus, Pfizer Inc., and etc.
---The combined market share of the Top 3 players in the global Opioid Withdrawal Syndrome market is about 66.34%.
REGION SHARE:
The report covers the market size information of major Regions/Countries around the world, including NA/United States, EU/Germany, APAC/China, LA/SA, MEA and etc.
---In the geographical distribution of Opioid Withdrawal Syndrome market in 2022, the North America has the largest market size and its market share is about 74.15%, followed by Europe and its market share is about 15.62%.
SEGMENT OVERVIEW:
This report conducts segment analysis on type and application level. Type segment includes Lucemyra (Lofexidine), Methadone, etc. Application segment includes Hospital, Clinic, etc.
---Buprenorphine contributes approximately 49.82% share to the market in 2022.
---Hospital contributes approximately 69.04% share to the market in 2022.
The cumulative impact of COVID-19, Russia-Ukraine conflict, and high inflation is expected to have a significant long-term impact on the global Opioid Withdrawal Syndrome markets. Ongoing research considers changes in consumer behavior, supply chain disruptions, and government intervention caused by the pandemic. Likewise, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine conflict and its potential impact on the supply-demand balance, pressure on pricing variables, and import, export, and trade. In addition, the report discusses the impact of high inflation on the global economy and details fiscal policies to measure and reduce its impact on demand, supply, cash flows, and currency exchange.
Market Statistics:
Reports provide market sizes and forecasts for multiple major currencies (USD, EUR, JPY, GBP, CNY, etc.); multi-currency support helps organizational leaders make informed decisions. This report takes 2018-2021 as the historical year, 2022 as the base year, 2023 as the semi-forecast year, and 2024-2029 as the full forecast year.
Market Share Analysis:
Market share analysis provides deep insights into the current status of vendors in a particular market space. By comparing suppliers” contributions to total revenue, customer base, and other key metrics, we can give companies a better understanding of their performance and the challenges they face as they compete for market share. The analysis also sheds light on the competitiveness of any given sector in terms of accumulation, diversification of strengths, and consolidation characteristics during the base year studied.
The report provides insights on the following metrics:
Market Penetration: Provides comprehensive information on the market offered by key players
Market Diversification: Provides detailed information on new product launches, greenfield regions, recent developments and investments
Market Trends: A Big Picture of the Cumulative Impact of COVID-19, Russia-Ukraine Conflict, and High Inflation
Competitive assessment and intelligence: Provides an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape and manufacturing capabilities of leading players
Product Development & Innovation: Provides intelligent insights into future technologies, R&D activities, and breakthrough product developments
Market Segmentation: Segment by Type, Application, and Region to provide detailed insights into market information.
Medication-Assisted Treatment (MAT): MAT combines the use of medications, such as methadone, buprenorphine, and naltrexone, with counseling and behavioral therapies to address opioid addiction and withdrawal. MAT has gained recognition as an effective approach and has seen increased adoption in various healthcare settings.
Opioid Withdrawal Medications: Several medications are used specifically for managing opioid withdrawal symptoms. These include clonidine, which can help with anxiety, agitation, and muscle aches, as well as medications like lofexidine and buprenorphine/naloxone combination products that are approved for opioid withdrawal symptom management.
Digital Health Solutions: The use of digital health technologies, including mobile apps and online platforms, has gained traction in the field of substance use disorders. These technologies can provide support, resources, and monitoring for individuals experiencing opioid withdrawal and can be integrated into comprehensive treatment approaches.
Policy and Regulation: Governments and healthcare organizations have implemented various policies and regulations to address the opioid crisis. This includes initiatives to increase access to addiction treatment services, improve prescribing practices, and enhance public education and awareness about opioid use and its associated risks.
Highlights-Regions
North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Nordic
Latin America
Brazil
Argentina
Mexico
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Player list
Indivior
Alkermes
Mallinckrodt Pharmaceuticals
Camurus
Pfizer Inc.
Rhodes Pharmaceuticals L.P.
USWM , LLC
Teva Pharmaceutical Industries Ltd
Types list
Lucemyra (Lofexidine)
Methadone
Buprenorphine
Naltrexone
Others
Application list
Hospital
Clinic
Others
Contact US Anytime
- Tel: +86 195 30455980
- Email: reports@arstaresearch.com
Find More
Post-Covid-19 Epidemic Era, Opioid Withdrawal Syndrome Industry Development Trend Analysis Report 2023
Get a FREE sample
Have Requests? Need Customization? Our Research Team Will Help to Maximize Your "Interest Scope and Content Customization" into Our Analysis Report.
Custom Research